ILX Stock Overview
Provides healthcare technological solutions in Israel, South Africa, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Ilex Medical Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪74.83 |
52 Week High | ₪84.99 |
52 Week Low | ₪56.00 |
Beta | -0.14 |
1 Month Change | 15.51% |
3 Month Change | 18.97% |
1 Year Change | 30.12% |
3 Year Change | -52.88% |
5 Year Change | -9.77% |
Change since IPO | 2,253.97% |
Recent News & Updates
Ilex Medical Ltd's (TLV:ILX) 26% Share Price Surge Not Quite Adding Up
Dec 06We Think Ilex Medical Ltd's (TLV:ILX) CEO Compensation Package Needs To Be Put Under A Microscope
Sep 24Earnings Troubles May Signal Larger Issues for Ilex Medical (TLV:ILX) Shareholders
Sep 04Recent updates
Ilex Medical Ltd's (TLV:ILX) 26% Share Price Surge Not Quite Adding Up
Dec 06We Think Ilex Medical Ltd's (TLV:ILX) CEO Compensation Package Needs To Be Put Under A Microscope
Sep 24Earnings Troubles May Signal Larger Issues for Ilex Medical (TLV:ILX) Shareholders
Sep 04Ilex Medical Ltd (TLV:ILX) Investors Are Less Pessimistic Than Expected
Jan 02Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Feb 13The Trend Of High Returns At Ilex Medical (TLV:ILX) Has Us Very Interested
Nov 25Returns On Capital Are A Standout For Ilex Medical (TLV:ILX)
Jun 03Here's Why We Think Ilex Medical (TLV:ILX) Is Well Worth Watching
May 04Ilex Medical (TLV:ILX) Could Easily Take On More Debt
Apr 02Is It Smart To Buy Ilex Medical Ltd (TLV:ILX) Before It Goes Ex-Dividend?
Mar 20Ilex Medical (TLV:ILX): Are Investors Overlooking Returns On Capital?
Mar 02Are Robust Financials Driving The Recent Rally In Ilex Medical Ltd's (TLV:ILX) Stock?
Feb 16What Type Of Shareholders Make Up Ilex Medical Ltd's (TLV:ILX) Share Registry?
Feb 04Here's Why I Think Ilex Medical (TLV:ILX) Is An Interesting Stock
Jan 24Shareholders of Ilex Medical (TLV:ILX) Must Be Delighted With Their 333% Total Return
Jan 11Ilex Medical (TLV:ILX) Has A Rock Solid Balance Sheet
Dec 23What Can We Make Of Ilex Medical's (TLV:ILX) CEO Compensation?
Nov 28Shareholder Returns
ILX | IL Healthcare | IL Market | |
---|---|---|---|
7D | -8.6% | 0.2% | -0.5% |
1Y | 30.1% | 25.4% | 23.0% |
Return vs Industry: ILX exceeded the IL Healthcare industry which returned 26.8% over the past year.
Return vs Market: ILX exceeded the IL Market which returned 23.2% over the past year.
Price Volatility
ILX volatility | |
---|---|
ILX Average Weekly Movement | 4.3% |
Healthcare Industry Average Movement | 3.4% |
Market Average Movement | 4.2% |
10% most volatile stocks in IL Market | 8.0% |
10% least volatile stocks in IL Market | 3.0% |
Stable Share Price: ILX has not had significant price volatility in the past 3 months compared to the IL market.
Volatility Over Time: ILX's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | 223 | Tammy Galili | www.ilexmedical.com |
Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services.
Ilex Medical Ltd Fundamentals Summary
ILX fundamental statistics | |
---|---|
Market cap | ₪844.13m |
Earnings (TTM) | ₪54.81m |
Revenue (TTM) | ₪982.96m |
15.4x
P/E Ratio0.9x
P/S RatioIs ILX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ILX income statement (TTM) | |
---|---|
Revenue | ₪982.96m |
Cost of Revenue | ₪753.08m |
Gross Profit | ₪229.88m |
Other Expenses | ₪175.07m |
Earnings | ₪54.81m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 4.86 |
Gross Margin | 23.39% |
Net Profit Margin | 5.58% |
Debt/Equity Ratio | 0.06% |
How did ILX perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield28%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 12:01 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ilex Medical Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|